top of page
detectchip_logo.png

Next-generation microfluidic nucleic acid detection system empowered with CRISPR

Our Mission

We wish to change the way disease diagnostics are carried out, by developing accessible, efficient, and cost-effective solutions that reduce waiting times and anxiety associated with disease testing. Our mission is to empower individuals and healthcare providers with reliable diagnostic tools that can allow proactive health management with fast tests to achieve diseases prevention and also re-examination after treatment.

Nurse Talking to Patient
Accurate

CRISPR-based diagnostics increase the isothermal amplification methods to PCR level sensitivity

Father and Son
Private
Image by Sasun Bughdaryan
Economical and deployable
Running Group
Rapid

Privacy at home - Conducting molecular testing at home ensures true confidentiality of your results

Plastic microfluidic chips and small footprint detector allows for the streamlined isothermal reactions at low cost

Rapid results reported within 30 minutes

Detecting the Undetectable: The Science behind Detectchip

Version render (1)_edited.jpg

Orange Biotech is the provider of diagnostics based on CRISPR technology, to overcome the drawbacks of common isothermal nucleic acid testing such as LAMP. Our sensitive, accurate, and affordable solution, the detectchip system, is designed to be easy to use and highly deployable, even to individuals. We aim to provide the highest quality testing, while keeping costs low and accessibility high. Contact us today to learn more about how we can help you.

Innovative Microfluidic Technology for Diagnostics

chip_design1.jpg

Here at Detectchip, we want to disrupt the diagnostic industry with our cutting-edge microfluidic chip technology. Our  disposable chip offers affordable and efficient diagnostics with mult-disease detection in one test.  Our system allows a lab on chip solution to control the reagent reaction and flow automatically, making it even easier for healthcare professionals to accurately diagnose patients.

bottom of page